Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
AN2 Therapeutics, Inc. (ANTX)
NASDAQ:ANTX
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jan 07, 2025 | xxxxxxxxxxxxx | $2719 | |
| Jan 07, 2025 | Eizen Joshua M Coo And Clo | xxxxxxxxxxxxx | $12948 |
| Dec 10, 2024 | Robin Shane Readnour Director | xxxxxxxxxxxxx | $86407 |
| Nov 27, 2024 | Joseph Zakrzewski Director | xxxxxxxxxxxxx | $2800 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,749,432 | Insider | 19.24% | 6,439,364 | |
| 2,382,472 | Insider | 7.97% | 2,668,369 | |
| 1,999,997 | Institution | 6.69% | 2,239,997 | |
| 1,572,170 | Insider | 5.20% | 1,760,830 | |
| 1,488,889 | Insider | 5.00% | 1,667,556 | |
| 1,243,938 | Insider | 4.16% | 1,393,211 | |
| 1,145,779 | Insider | 3.80% | 1,283,272 | |
| 1,011,352 | Institution | 3.38% | 1,132,714 | |
| 1,011,352 | Institution | 3.38% | 1,132,714 | |
| 540,895 | Insider | 1.81% | 605,802 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,011,352 | Institution | 3.38% | 1,132,714 | |
| 196,173 | Institution | 0.66% | 219,714 | |
| 194,500 | Institution | 0.65% | 217,840 | |
| 17,261 | Institution | 0.06% | 19,332 | |
| 5,580 | Institution | 0.02% | 6,250 | |
| 1,347 | Institution | <0.01% | 1,509 | |
| 460 | Institution | <0.01% | 515 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 749,421 | Institution | 2.51% | 1,034,201 | |
| 261,931 | Institution | 0.88% | 361,465 | |
| 35,702 | Institution | 0.12% | 39,986 |
FAQ
Who Owns AN2 Therapeutics, Inc. (ANTX)?
Currently, no data Available
What percentage of AN2 Therapeutics, Inc. (ANTX) stock is held by institutional investors?
Currently, no data Available
What percentage of AN2 Therapeutics, Inc. (ANTX) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of AN2 Therapeutics, Inc. (ANTX)?
Braden Michael Leonard owns the most shares of AN2 Therapeutics, Inc. (ANTX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.